| Authors: |
Singleton SP; Department of Computational Biology, Cornell University, Ithaca, NY, United States., Wang JB; MAPS Public Benefit Corporation, San Jose, CA, United States., Mithoefer M; MAPS Public Benefit Corporation, San Jose, CA, United States.; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States., Hanlon C; Wake Forest School of Medicine, Winston-Salem, NC, United States., George MS; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.; Ralph H. Johnson VA Medical Center, Charleston, SC, United States., Mithoefer A; MAPS Public Benefit Corporation, San Jose, CA, United States., Mithoefer O; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States., Coker AR; MAPS Public Benefit Corporation, San Jose, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Yazar-Klosinski B; Multidisciplinary Association for Psychedelic Studies, San Jose, CA, United States., Emerson A; MAPS Public Benefit Corporation, San Jose, CA, United States., Doblin R; Multidisciplinary Association for Psychedelic Studies, San Jose, CA, United States., Kuceyeski A; Department of Computational Biology, Cornell University, Ithaca, NY, United States.; Department of Radiology, Weill Cornell Medicine, New York, NY, United States. |
